author-photo

Elaine Chan

Icahn School of Medicine at Mount Sinai

10

Papers

86

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Recapturing Disease Response: A Phase 2 Study of Carfilzomib 56 mg/m2 in Patients with Relapsed or Refractory Multiple Myeloma Who Have Progressed on Carfilzomib 27 mg/m2

2019 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (0)
A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma

2017 Blood Advances
Show All
- Source
- Cite
- Save
Citations (46)
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

2016 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Phase 1 Study of Elotuzumab in Combination with Autologous Stem Cell Transplantation and Lenalidomide Maintenance for Multiple Myeloma

2016 Blood
Show All
- Source
- Cite
- Save
Citations (1)
A Phase II Study of Panobinostat with Lenalidomide and Weekly Dexamethasone in Myeloma

2015 Blood
Show All
- Source
- Cite
- Save
Citations (6)
Recapturing Disease Response: A Phase II Study of High Dose Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma Who Have Progressed on Standard Dose Carfilzomib

2015 Blood
Show All
- Source
- Cite
- Save
Citations (2)